Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.86 |
| ▸ | TSHR | P16473 | 3/20 | 0.86 |
| ▸ | ATM | Q13315 | 1/20 | 0.86 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.86 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31486463 | 0.95 | TSHR (0.77) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL44320 | 0.94 | CYP3A4 (0.89) | CYP3A4TSHRATMTDP1RECQL | |
| Calcium SCHEMBL31454404 | 0.93 | CYP3A4 (0.86) | CYP3A4TSHRATMTDP1RECQL | |
| Ammonia Solution, Strong SCHEMBL16192512 | 0.93 | CYP3A4 (0.86) | CYP3A4TSHRATMTDP1RECQL | |
| Magnesium SCHEMBL31454400 | 0.93 | CYP3A4 (0.86) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL247018 | 0.93 | CYP3A4 (0.93) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL6014128 | 0.93 | CYP3A4 (0.86) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL27423 | 0.93 | CYP3A4 (1.00) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL3849332 | 0.93 | CYP3A4 (0.93) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL1336595 | 0.93 | CYP3A4 (0.86) | CYP3A4TSHRATMTDP1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185759-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | EASTMAN CHEMICAL COMPANY (US) | 2022-06-16 | — | — | US | claimed |
| EP-3947337-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | EASTMAN CHEMICAL COMPANY (US) | 2022-02-09 | — | — | EP | claimed |
| US-11225449-B2 | Optimization of 2-EH product recovery system using process intensification | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-01-18 | — | — | US | claimed |
| CN-113597423-A | Process for producing carboxylic acid | 伊士曼化工公司 | 2021-11-02 | — | — | CN | claimed |
| WO-2020205348-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | EASTMAN CHEMICAL COMPANY (US) | 2020-10-08 | — | — | WO | claimed |
| EP-3169439-B1 | STABLE AQUEOUS COMPOSITION OF NEUTRAL COLLECTORS AND THEIR USE IN MINERAL BENEFICIATION PROCESSES | CLARIANT INT LTD (CH) | 2020-09-30 | — | — | EP | claimed |
| US-10105713-B2 | Stable aqueous composition of neutral collectors and their use in mineral beneficiation processes | CLARIANT INTERNATIONAL LTD. (CH) | 2018-10-23 | — | — | US | claimed |
| US-20170165681-A1 | Stable Aqueous Composition Of Neutral Collectors And Their Use In Mineral Beneficiation Processes | CLARIANT INTERNATIONAL LTD. (CL) | 2017-06-15 | — | — | US | claimed |
| EP-3169439-A1 | STABLE AQUEOUS COMPOSITION OF NEUTRAL COLLECTORS AND THEIR USE IN MINERAL BENEFICIATION PROCESSES | Clariant International Ltd (CH) | 2017-05-24 | — | — | EP | claimed |
| US-9550909-B2 | Polyvinyl acetal resin, slurry composition prepared therefrom, ceramic green sheet, and multilayer ceramic capacitor | KURARAY CO., LTD. (JP) | 2017-01-24 | — | — | US | claimed |
| US-8534464-B2 | Collecting agent and method for floatation of insoluble components of raw salts | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-09-17 | — | — | US | claimed |
| US-8496115-B2 | Foaming agent and method for floatation of insoluble components of raw salts | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-07-30 | — | — | US | claimed |
| CN-102603986-A | Surface solid phase graft modified PVDF (Polyvinylidene Fluoride) and preparation method thereof | UNIV CHANGZHOU | 2012-07-25 | — | — | CN | claimed |
| US-20110290704-A1 | Foaming Agent And Method For Floatation Of Insoluble Components Of Raw Salts | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-12-01 | — | — | US | claimed |
| US-20110236341-A1 | COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A NON-VOLATILE OIL | L'OREAL (FR) | 2011-09-29 | — | — | US | claimed |
| CN-101525464-B | Novel material for totally nontoxic non-polyvinyl chloride medical perfusion tube and method for manufacturing same | ZHEJIANG SANBO POLYMERS CO LTD | 2011-04-20 | — | — | CN | claimed |
| CN-101525464-A | Novel material for totally nontoxic non-polyvinyl chloride medical perfusion tube and method for manufacturing same | ZHEJIANG SANBO POLYMERS CO LTD | 2009-09-09 | — | — | CN | claimed |
| EP-0900836-B2 | Additive for mineral oils and mineral oil distillates flowability improvement | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2008-06-11 | — | — | EP | claimed |
| EP-0900836-B1 | Additive for mineral oils and mineral oil distillates flowability improvement | CLARIANT GMBH (DE) | 2003-11-05 | — | — | EP | claimed |
| US-6010989-A | ETHYLENE-VINYL ESTER INTERPOLYMER; PARAFFIN DISPERSANT; ALIPHATIC OR CYCLIC ESTER OR ETHER SOLUBILIZER | CLARIANT GMBH (DE) | 2000-01-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185759-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | HAO2, HPD, DDO | CYP3A4 174/4885TSHR 4552/4885ATM 3872/4885 |
| US-20110236341-A1 | COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A NON-VOLATILE OIL | KRT18, CUTA, DSG1 | CYP3A4 3730/4885TSHR 4187/4885ATM 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.